Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22
Sex
Women only
Ages
Ages 30 Years to 60 Years
Primary completion
2025-12-22
Last update
2026-03-23

What this trial studies

It is the purpose of this clinical trial to examine the feasibility and acceptability of a brief online physical activity group (incorporating motivational interviewing) for UK women who are currently experiencing peri- or post-menopausal symptoms and working full-time. To measure feasibility and acceptability, the following will be examined: 1. The ease that participants were recruited; 2. The proportion of participants that remained in the online physical activity group (attending at least half of the sessions); 3.

Conditions in scope

  • Perimenopausal Women
  • Postmenopausal

Interventions

  • Online Physical Activity Group (Behavioral) — The online physical activity group will consist of four 45-60-minute sessions, which participants allocated to this group will be asked to commit to. These sessions will be delivered online and occur for 4 weeks. Discussions within the sessions will incorporate…
  • Information Leaflet (Behavioral) — Participants will receive an information leaflet that includes information about menopause (e.g. definition, symptoms), the benefits of physical activity for menopause, recommended weekly physical activity levels (based on CMO guidelines), examples of physical activity, and signposting to online resources. Participants…

Who can join

Women only · Ages 30 Years to 60 Years

Inclusion criteria

  • Female
  • Aged 30-60 years
  • Currently working full-time (approximately 35+ hours per week)
  • Currently experiencing perimenopausal (women with newly inconsistent menstrual cycles, \>1 year since last cycle) or post-menopausal (cessation of menstrual cycle for \>12 months) symptoms, which are impacting functioning
  • Currently physically inactive or not meeting recommended government guidelines (150-minutes of moderate-vigorous physical activity per week)
  • No comorbid health conditions that impact ability to participate in physical activity

Exclusion criteria

  • See ClinicalTrials.gov for full exclusion criteria.

Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.

Where it’s happening

CityState / RegionFacilitySite status
Royal Tunbridge Wells Kent Salomons Institute for Applied Psychology, Canterbury Christ Church University Unknown

Status & timeline

  • Overall status: Completed
  • Study type: Interventional
  • Phase: N/A
  • Start date: 2025-05-29
  • Primary completion: 2025-12-22
  • Last update posted: 2026-03-23
  • First posted: 2025-02-12

Lead sponsor: Canterbury Christ Church University (Other)

For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.

Outcome measures

Primary outcomes

  • Number of participants recruited to the study (9 months from the start of recruitment)
    The number of participants recruited will be compared to pre-defined progression criteria, based on existing literature, to examine the feasibility of recruitment. This progression criteria will follow a traffic light system; Green = 40-50 participants, Amber = \>24 participants, Red = \<24 participants.
  • Retention rate of participants attending the online intervention (Week 0 to 8-9)
    The proportion of participants who attend at least half of the online physical activity group sessions, which will be compared to progression criteria; Green = \>50%, Amber = 25-49%, Red = \<25%.
  • The retention rate of participants who remain in the study as a whole (Week 0 to 12-13)
    The proportion of participants who remain in the study, compared to progression criteria: Green = \>50%, Amber = 25-49%, Red = \<25%
  • Acceptability of the online physical activity group intervention (Week 8-9)
    Participant responses to the feedback questionnaire, including Likert-scale questions and content analysis of qualitative questions. This will be compared to progression criteria; Green = High satisfaction/acceptability from the majority of participants, with a mean of 7/10 on the Likert-scale questions, Amber = Moderate/Inconsistent satisfaction and acceptability indicated, Red = Low satisfaction/acceptability from the majority of participants
  • Preliminary indicator of effectiveness for the primary outcome (physical activity) (Week 8-9 and 12-13)
    Estimate of the between group effect size for the online physical activity group compared to control group on the International Physical Activity Questionnaire-Short Form (IPAQ-SF), from baseline \[Week 0 - 1\] to post-intervention and follow-up \[Week 8-9 and Week 12-13, respectively\]. This will be compared to progression criteria; Green = the between-group effect size is in favour of the intervention,…

If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.

Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT06821841 before contacting a site.

ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.